Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.

Orré M, Latorzeff I, Fléchon A, Roubaud G, Brouste V, Gaston R, Piéchaud T, Richaud P, Chapet O, Sargos P.

PLoS One. 2017 Apr 6;12(4):e0174978. doi: 10.1371/journal.pone.0174978. eCollection 2017.

2.

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).

Lázaro M, Gallardo E, Doménech M, Pinto Á, Del Alba AG, Puente J, Fernández O, Font A, Lainez N, Vázquez S.

Clin Transl Oncol. 2016 Dec;18(12):1197-1205. Epub 2016 Nov 29.

3.

Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Tan WS, Khetrapal P, Tan WP, Rodney S, Chau M, Kelly JD.

PLoS One. 2016 Nov 7;11(11):e0166221. doi: 10.1371/journal.pone.0166221. eCollection 2016.

4.

A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis.

Li F, Hong X, Hou L, Lin F, Chen P, Pang S, Du Y, Huang H, Tan W.

Oncotarget. 2016 Sep 20;7(38):61284-61294. doi: 10.18632/oncotarget.11343.

5.

Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort.

Corradi RB, Galvao GJ, Oliveira GM, Carneiro VF, Miconi WG, Salles PG, Cabral WL, Corradi C, Salazar AL.

Int Braz J Urol. 2016 May-Jun;42(3):431-7. doi: 10.1590/S1677-5538.IBJU.2015.0380.

6.

Is [F-18]-fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer?

Uttam M, Pravin N, Anish B, Nandita K, Arup M.

Int Braz J Urol. 2016 Mar-Apr;42(2):234-41. doi: 10.1590/S1677-5538.IBJU.2014.0579.

7.

Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.

Eapen LJ, Jones E, Kassouf W, Lambert C, Morgan SC, Moussa M, Nam R, Parliament M, Russell L, Saad F, Siemens DR, Souhami L, Szumacher E, Tyldesley S, Xu Y, Zbieranowski I, Breau RH, Belanger E, Black P, Estey E, Bowan J, Bora B, Brundage M, Chung P, Fleshner N, Evans A, Bauman G, Izawa J, Davidson C, Brimo F.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):90-4. doi: 10.5489/cuaj.3456.

8.

Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer.

Attaallah W, Uprak K, Gunal O, Yegen C.

Indian J Surg Oncol. 2016 Mar;7(1):67-72. doi: 10.1007/s13193-016-0490-8. Epub 2016 Jan 9.

9.

Ureterocutaneostomy: for whom and when?

Kozacıoğlu Z, Değirmenci T, Günlüsoy B, Ceylan Y, Minareci S.

Turk J Urol. 2013 Sep;39(3):143-6. doi: 10.5152/tud.2013.030.

10.

Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer.

Qiang G, Liang C, Yu Q, Xiao F, Song Z, Tian Y, Shi B, Liu D, Guo Y.

Thorac Cancer. 2015 Mar;6(2):166-71. doi: 10.1111/1759-7714.12159. Epub 2015 Mar 2.

11.

Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.

Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH.

BMC Cancer. 2015 Jun 2;15:447. doi: 10.1186/s12885-015-1448-x. Review.

12.

Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?

Ugurlu O, Baltaci S, Aslan G, Can C, Cal C, Elhan A, Turkeri L, Mungan A.

Korean J Urol. 2015 May;56(5):357-64. doi: 10.4111/kju.2015.56.5.357. Epub 2015 Apr 28.

13.

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.

Kim HS, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH.

Sci Rep. 2015 May 11;5:9626. doi: 10.1038/srep09626.

14.

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study.

Qin X, Zhang H, Wan F, Zhu Y, Shen Y, Dai B, Shi G, Zhu Y, Ye D.

World J Surg Oncol. 2015 Mar 31;13:132. doi: 10.1186/s12957-015-0561-2.

15.

Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?

Cha EK, Donahue TF, Bochner BH.

Urol Clin North Am. 2015 May;42(2):189-99, viii. doi: 10.1016/j.ucl.2015.02.003. Epub 2015 Feb 28. Review.

16.

Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma.

Gamboa AJ, Young JL, Dash A, Abraham JB, Box GN, Ornstein DK.

J Robot Surg. 2009;3(1):7-12. doi: 10.1007/s11701-009-0124-z. Epub 2009 Feb 4.

17.

Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.

Tang K, Li H, Xia D, Hu Z, Zhuang Q, Liu J, Xu H, Ye Z.

PLoS One. 2014 May 16;9(5):e95667. doi: 10.1371/journal.pone.0095667. eCollection 2014. Review.

19.

Racial variation in the quality of surgical care for bladder cancer.

Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA Jr, Penson DF.

Cancer. 2014 Apr 1;120(7):1018-25. doi: 10.1002/cncr.28520. Epub 2013 Dec 11.

20.

Multi-institutional investigation of the prognostic value of lymph nodel yield in advanced-stage oral cavity squamous cell carcinoma.

Jaber JJ, Zender CA, Mehta V, Davis K, Ferris RL, Lavertu P, Rezaee R, Feustel PJ, Johnson JT.

Head Neck. 2014 Oct;36(10):1446-52. doi: 10.1002/hed.23475. Epub 2014 Jan 13.

Supplemental Content

Support Center